Stomach cancer surgery combo trial fizzles: only 6 patients enrolled

NCT ID NCT03042169

Terminated Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding surgery to chemotherapy helps people with stage IV stomach cancer that has spread to only one other area. The goal was to see if surgery could improve survival and quality of life. However, the trial was stopped early after enrolling only 6 participants, so no strong conclusions can be drawn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: chemotherapy and surgery
What this could lead to: If it had succeeded, this could have shown that surgery plus chemotherapy improves survival for some patients with stage IV gastric cancer that has spread to only one other site.
What could go wrong: The trial was terminated early with only 6 participants, so results are very limited. It is unclear if the approach is truly beneficial, and surgery carries risks like complications and recovery time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC ADENOCARCINOMA

Contacts and locations

Locations

Ico - Site Gauducheau - St Herblain

Saint-Herblain, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.